Trials / Completed
CompletedNCT02738424
Reproductibility of Lumbar Spine ADC Based on Different Post-processing Softwares
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Lumbar spine bone marrow is well explored in Magnetic Resonance Imaging (MRI) but some bone marrow diseases are hard to analyze with this method. Furthermore, there is heterogeneity in normal bone marrow, called apparent diffusion coefficient (ADC). Histological and technical factors appear to be the cause, but the possible influence of the employed post-processing software has never yet been evaluated. The purpose of this study is to determine if there is variability in lumbar bone ADC related to the post-processing software.
Detailed description
Lumbar spine bone marrow is well explored in MRI. Some bone marrow diseases are hard to analyze in conventional MRI, and diffusion-weighted imaging (DWI) could be an additional diagnostic feature. However, according to the literature, there is heterogeneity in normal bone marrow of the quantitative parameter that it provides, called apparent diffusion coefficient (ADC). Histological and technical factors appear to be the cause, but the possible influence of the employed post-processing software has never yet been evaluated. The purpose of this study is to determine if there is variability in lumbar bone ADC related to the post-processing software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Calculate the ADC scores | The MRI will be performed on the two groups of patients in the usual care. The intervention will be based on the ADC scores calculation. The scores will be obtained with three types of post-processing softwares : Siemens, PACS Carestream, Osirix. |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-11-16
- Completion
- 2015-11-16
- First posted
- 2016-04-14
- Last updated
- 2023-07-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02738424. Inclusion in this directory is not an endorsement.